SCHEMBL1107838

SCHEMBL1107838

Cc1cc(C)cc(CC(NC2=NCCS2)c2cc(Br)ccc2F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.37
HPGD P15428 2/20 0.36
L3MBTL1 Q9Y468 4/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 3/20 0.35
TAAR1 Q96RJ0 1/20 0.35
NPC1 O15118 6/20 0.34
RAB9A P51151 6/20 0.34
KDM4E B2RXH2 2/20 0.34
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
USP2 O75604 1/20 0.33
POLB P06746 1/20 0.33
ALOX15 P16050 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1107811 0.90 SMN1; SMN2 (0.39) SMN1; SMN2HPGDL3MBTL1LMNATAAR1
SCHEMBL1107843 0.89 SMN1; SMN2 (0.38) SMN1; SMN2HPGDL3MBTL1LMNATAAR1
SCHEMBL1107824 0.85 L3MBTL1 (0.43) SMN1; SMN2L3MBTL1HTTLMNATAAR1
SCHEMBL1107849 0.83 SMN1; SMN2 (0.37) SMN1; SMN2HPGDL3MBTL1HTTLMNA
SCHEMBL1107839 0.81 SMN1; SMN2 (0.38) SMN1; SMN2HPGDL3MBTL1LMNATAAR1
SCHEMBL1107807 0.80 NPC1 (0.42) SMN1; SMN2HPGDL3MBTL1LMNATAAR1
SCHEMBL1107842 0.79 KMT2A (0.46) SMN1; SMN2HPGDLMNATAAR1NPC1
SCHEMBL27866325 0.79 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1LMNATAAR1NPC1
SCHEMBL14095750 0.79 SMN1; SMN2 (0.37) SMN1; SMN2HPGDL3MBTL1LMNATAAR1
SCHEMBL1107864 0.77 ATM (0.43) SMN1; SMN2L3MBTL1LMNATAAR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153560-B2 Pesticidal active mixtures comprising aminothiazoline compounds BASF SE (DE) 2012-04-10 US disclosed
US-8153560-B2 Pesticidal active mixtures comprising aminothiazoline compounds BASF SE (DE) 2012-04-10 US disclosed
US-20100056469-A1 Pesticidal Active Mixtures Comprising Aminothiazoline Compounds BASF SE (DE) 2010-03-04 US disclosed
US-20100056469-A1 Pesticidal Active Mixtures Comprising Aminothiazoline Compounds BASF SE (DE) 2010-03-04 US disclosed
WO-2008104503-A1 PESTICIDAL ACTIVE MIXTURES COMPRISING AMINOTHIAZOLINE COMPOUNDS BASF SE (DE) 2008-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056469-A1 Pesticidal Active Mixtures Comprising Aminothiazoline Compounds ACHE, PTMS, CHRM3 SMN1; SMN2 4497/4885HPGD 4354/4885L3MBTL1 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.